ID   GIST-T1/IM-R
AC   CVCL_C3M2
DR   Wikidata; Q116049078
RX   PubMed=34738628;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI:45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Mutation; HGNC; 6342; KIT; Simple; p.Val560_Tyr578del (c.1679_1735del); Zygosity=Heterozygous (PubMed=34738628).
CC   Sequence variation: Mutation; HGNC; 8803; PDGFRA; Simple; p.Pro567Pro (c.1701A>G); ClinVar=VCV000259949; Zygosity=Unspecified (PubMed=34738628).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Interstitial cell of Cajal; CL=CL_0002088.
DI   NCIt; C3868; Gastrointestinal stromal tumor
DI   ORDO; Orphanet_44890; Gastrointestinal stromal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4976 ! GIST-T1
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 4
//
RX   PubMed=34738628; DOI=10.3892/or.2021.8218;
RA   Shima T., Taniguchi K., Tokumaru Y., Inomata Y., Arima J., Lee S.-W.,
RA   Takabe K., Yoshida K., Uchiyama K.;
RT   "Glucose transporter-1 inhibition overcomes imatinib resistance in
RT   gastrointestinal stromal tumor cells.";
RL   Oncol. Rep. 47:7.1-7.13(2022).
//